非酒精性脂肪性肝病的治疗进展  

Advances in the treatment of nonalcoholic fatty liver disease

作　　者：牛海艳[1] 李海[1] 丁玉平[1] 

机构地区：[1]中国人民武装警察部队后勤学院附属医院肝胆胰脾科(消化二科),天津300162

出　　处：《临床肝胆病杂志》2018年第2期433-437,共5页Journal of Clinical Hepatology

基　　金：武警后勤学院博士启动基金(WHB201517)

摘　　要：非酒精性脂肪性肝病(NAFLD)在我国的发病率逐年攀升,已是严重影响我国居民健康的常见慢性疾病。介绍了生活方式的干预在NAFLD治疗中的地位,简述了药物在NAFLD治疗中的种类与价值,总结了改善肠道菌群在NAFLD治疗中的方法与途径,分析了外科手术干预在NAFLD治疗中的临床获益与经济效价。指出加强对NAFLD患者的有效管理可能是未来对该疾病治疗的一个新研究方向。The incidence rate of nonalcoholic fatty liver disease（NAFLD） has been increasing year by year in China,and NAFLD has become one of the common chronic diseases that affect the health of Chinese residents.This article introduces the role of lifestyle intervention,reviews the types of drugs used in the treatment of NAFLD and their value,summarizes the methods and approaches for improving intestinal flora,and analyzes the clinical and economic benefits of surgical intervention in the treatment of NAFLD.It is pointed out that strengthening the effective management of patients with NAFLD may be a new research direction in the future for the treatment of this disease.

关 键 词：脂肪肝 治疗 综述 

分 类 号：R575.5[医药卫生—消化系统]